Early Access

10-QPeriod: Q1 FY2023

ECOLAB INC. Quarterly Report for Q1 Ended Mar 31, 2023

Filed May 4, 2023For Securities:ECL

Summary

Ecolab Inc. reported strong first-quarter 2023 results, demonstrating resilience and growth in a dynamic economic environment. Net sales increased by 9% year-over-year to $3.57 billion, driven by a 13% increase in organic sales, indicating robust underlying business performance. This growth was primarily fueled by effective pricing strategies across all segments, which more than offset increased delivered product costs. The company's operating income saw a significant increase of 38% to $351.6 million, reflecting improved operational efficiencies and strong sales execution. The company's diversified business segments, including Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences, all contributed positively to the top-line growth, with particular strength noted in water treatment, food & beverage, and life sciences. Despite inflationary pressures and foreign currency headwinds, Ecolab maintained a disciplined approach to cost management and strategic investments, leading to a notable improvement in profitability. The company's balance sheet remains solid, with sufficient liquidity to support ongoing operations and strategic initiatives.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased by 9% to $3.57 billion in Q1 2023, with organic sales growing by 13%.
  • 2Operating income surged by 38% to $351.6 million, indicating strong profitability improvement.
  • 3All key segments (Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences) showed organic sales growth, demonstrating broad-based demand.
  • 4Gross margin improved to 38.3% from 36.5% in the prior year period, driven by effective pricing strategies.
  • 5The company maintained disciplined cost management, with SG&A as a percentage of sales decreasing slightly year-over-year.
  • 6Ecolab generated strong operating cash flow of $198.2 million, supporting investments and shareholder returns.
  • 7The company continues to manage its debt effectively, with a net debt to EBITDA ratio of 3.1 as of March 31, 2023.

Frequently Asked Questions